Physician profile
Matthew E Sims
NPI 1184119455
$8,965.61
in general payments reported to CMS, 2019-2025
39 companies · $1,679 in 2025
The $1,679 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2021: $797 · 2022: $815 · 2023: $2,951 · 2024: $2,285 · 2025: $1,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,700 · Travel and Lodging: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,699.87 |
| Travel and Lodging | $1,215.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,029.76 | 2019-2025 | Ams 700 Cxr Rte Kit, Axonics, Ams Ambicor |
| Urogen Pharma, INC. | $610.32 | 2022-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $556.85 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $439.97 | 2019-2022 | |
| Calyxo, INC. | $392.42 | 2025 | Cvac Aspiration System |
| Teleflex LLC | $378.61 | 2024-2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $371.44 | 2024-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $325.78 | 2023-2025 | Provenge |
| Medical Device Business Services, INC. | $305.00 | 2021 | |
| Medtronic, INC. | $285.26 | 2021-2024 | Interstim |
| Janssen Biotech, INC. | $268.65 | 2019-2025 | Erleada |
| Merck Sharp & Dohme LLC | $199.00 | 2023-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Ferring Pharmaceuticals INC. | $191.97 | 2023-2025 | Adstiladrin |
| Abbvie INC. | $168.29 | 2023-2025 | Botox |
| Angiodynamics, INC. | $151.40 | 2024 | Nanoknife |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $143.55 | 2024 | Bulkamid, Axonics |
| Neotract INC. | $102.83 | 2019 | |
| Olympus America INC. | $102.42 | 2023 | Itind System |
| Cook Medical LLC | $99.68 | 2021 | |
| Progenics Pharmaceuticals, INC. | $97.76 | 2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $82.37 | 2024-2025 | |
| Tolmar, INC. | $63.83 | 2025 | Jatenzo, Eligard |
| Coloplast Corp | $63.56 | 2023 | Titan, Speedicath |
| Ethicon US, LLC | $61.81 | 2022-2023 | Echelon Flex, Enseal, Dermabond |
| Accord Healthcare, INC. | $57.88 | 2025 | |
| Laborie Medical Technologies Corp. | $52.20 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $49.72 | 2022-2023 | Xiaflex |
| Medtronic USA, INC. | $48.71 | 2019 | |
| Verity Pharmaceuticals INC. | $44.77 | 2023-2025 | Trelstar |
| Pfizer INC. | $38.43 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $36.66 | 2023-2024 | Yonsa |
| Telix Pharmaceuticals | $32.34 | 2025 | Illuccix |
| Novartis Pharmaceuticals Corporation | $23.16 | 2025 | |
| Caris Mpi, INC. | $21.09 | 2025 | Mi Cancer Seek |
| Astrazeneca Pharmaceuticals LP | $17.92 | 2024 | Lynparza |
| Pacira Pharmaceuticals Incorporated | $16.60 | 2024 | Exparel |
| Sandoz INC. | $14.33 | 2025 | Wyost, Jubbonti |
| Valencia Technologies Corporation | $9.89 | 2025 | Ecoin Device Kit |
| Pharmaand Gmbh | $9.38 | 2024 | Rubraca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.